Clinical Scorecard: Mechanisms of Programmed Cell Death Induced by Traditional Herbal Medicine in the Treatment of Prostate Cancer

At a Glance

Key Highlights

• Traditional plant medicine (TPM) induces multiple forms of programmed cell death (PCD) in prostate cancer.
• Key molecular targets include PI3K/AKT/mTOR, AMPK/mTOR pathways, and others.
• Current therapies for prostate cancer face challenges such as tumor resistance and recurrence.

Guideline-Based Recommendations

Diagnosis

• Diagnosis of prostate cancer should consider the prevalence and mortality rates globally.

Management

• Explore the use of traditional plant medicines as adjunctive therapies in prostate cancer treatment.

Monitoring & Follow-up

• Monitor the effects of TPM on various forms of programmed cell death in prostate cancer.

Risks

• Consider the limitations of current prostate cancer therapies, including treatment-related toxicities.

Patient & Prescribing Data

Men diagnosed with prostate cancer, particularly those with treatment resistance.

TPM has shown efficacy in overcoming chemotherapeutic resistance and inducing apoptosis.

Clinical Best Practices

• Investigate the role of PCD modulators in refining therapeutic strategies for prostate cancer.
• Focus on the interrelationships between different modes of cell death in the context of TPM.

Related Resources & Content

• Prostate Cancer Statistics
• Traditional Medicine in Cancer Treatment